DTC status has been included in the new American Joint Committee on cancer classification.13 The presence of DTCs identified (at median 85 months follow‐up) a subgroup of luminal A patients characterized by high expression levels of ER‐related genes and low expression of the HER2 cluster and proliferation‐associated genes. Here, ERBB2 is linked to cancer.